Lifestyle and psychosocial factors in inflammatory bowel disease: Prevalence, impact, motivation, and support needs

Patients with IBD commonly report unfavorable lifestyle and psychosocial factors, recognize their impact on intestinal symptoms, and are motivated to change, but often lack hospital support. This underscores the importance for systematic incorporation of lifestyle and psychosocial factors into patient-centered IBD care and the potential for targeted interventions.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2025-08-29
DOI
https://doi.org/10.1371/journal.pone.0331092
Citations
1
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
1.82

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lifestyle and psychosocial factors in inflammatory bowel disease: Prevalence, impact, motivation, and support needs

Adriaan A. van Bodegraven, Mariëlle Romberg‐Camps, Menne PM. Scherpenzeel, Quirine M. Bredero et al.
1 citations
PLoS ONE
Inflammatory Bowel Disease
1.82
article

Lifestyle and psychosocial factors in inflammatory bowel disease: Prevalence, impact, motivation, and support needs

Adriaan A. van Bodegraven, Mariëlle Romberg‐Camps, Menne PM. Scherpenzeel, Quirine M. Bredero, Marieke J. Pierik, E M B Hendrix, Zlatan Mujagic, Merel Kimman, Daisy M.A.E. Jonkers, Karlijn Demers, Maya J. Schroevers, Ashkan Rezazadeh Ardabili, Tessa E H Römkens, Rachel West, Laurents P S Stassen, Gerard Dijkstra, Daniëlle van der Horst
article en
1 citations

Abstract

Patients with IBD commonly report unfavorable lifestyle and psychosocial factors, recognize their impact on intestinal symptoms, and are motivated to change, but often lack hospital support. This underscores the importance for systematic incorporation of lifestyle and psychosocial factors into patient-centered IBD care and the potential for targeted interventions.

PLoS ONEVol. 20(8)
University Medical Center Groningen (NL), University of Groningen (NL), Maastricht University Medical Centre (NL), Maastricht University (NL), Sint Franciscus Gasthuis (NL), Zuyderland Medisch Centrum (NL), Jeroen Bosch Ziekenhuis (NL)
Eli Lilly and Company, Pfizer, Teva Pharmaceutical Industries, European Commission, ZonMw, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Horizon 2020 Framework Programme, HORIZON EUROPE Framework Programme
Openalex Percentile: Top 13%
Inflammatory Bowel Disease
1.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.